Kidney & Urology Foundation of America
Kidney & Urology Foundation of America
SAVE THE DATE:
Support Walk the Walk
New York Walk the Walk

October 31, 2010 - Central Park
REGISTER ONLINE NOW!
join us on Facebook
Join KUFA today
and become an essential part of the fight to save and improve lives. There are no fees for patients, family and friends to get connected!

 

Patient Resources


Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Immunology | Family Medicine

COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials


A listing of COPD (Chronic Obstructive Pulmonary Disease) medical research trials actively recruiting patient volunteers. Click on the closest state and city to find more detailed information on a research study in your area.

Alabama

Birmingham : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Birmingham : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Birmingham : Achieve Clinical Research, LLC an Accel Research Site

Long term safety study of QVA149 in COPD patients with moderate to sever airflow limitation.

Andalusia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Andalusia : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Anniston : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Birmingham : UAB Lung Health Center

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Birmingham : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Birmingham : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Birmingham : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Birmingham : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Birmingham : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Birmingham : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Birmingham : Forest Investigative Site 3056

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Birmingham : Forest Investigative Site 3836

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Florence : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Florence : Forest Investigative Site 3438

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Foley : Forest Investigative Site 3729

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Huntsville : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Huntsville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Huntsville : Forest Investigative Site 3911

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Jasper : 1237.26.10620 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Jasper : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Jasper : Forest Investigative Site 2423

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Mobile : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Mobile : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Mobile : Forest Investigative Site 4030

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Montgomery : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Montgomery : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Montgomery : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Ozark : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pell City : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pisgah : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Tuscumbia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Arizona

Flagstaff : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Phoenix : Arizona Research Center

A Long-Term, Randomized, Double-Blind Study of the Safety, Tolerability and Efficacy of Aclidinium Bromide At Two Dosage Levels When Administered to Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease

Phoenix : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Phoenix : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Phoenix : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Phoenix : Elite Clinical Studies, LLC

Is COPD Leaving You Breathless? Right now we're enrolling adults with COPD ages 40 or older in a research study of an investigational medication for COPD.

Tucson : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Additional Locations : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Chandler : Forest Investigative Site 3731

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Chandler : Forest Investigative Site 3164

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Chandler : Forest Investigative Site 4015

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Flagstaff : Clinical Trial Connection

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Flagstaff : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Flagstaff : Forest Investigative Site 3904

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Glendale : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Mesa : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mesa : Forest Investigative Site 4032

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Phoenix : Pulmonary Associates P.A.

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Phoenix :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Phoenix : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Phoenix : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Phoenix : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Phoenix : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Phoenix : Forest Investigative Site 3850

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Phoenix : Forest Investigative Site 3135

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Phoenix : Forest Investigative Site 4003

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Scottsdale : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sierra Vista : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Tempe : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tempe : Forest Investigative Site 3968

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tempe : Forest Investigative Site 3673

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tempe : Forest Investigative Site 4024

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tempe : Forest Investigative Site 4031

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tucson : Novartis Investigative Site

A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Tucson : Forest Investigative Site 4046

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tucson : Forest Investigative Site 4016

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tucson : Forest Investigative Site 3917

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tucson : Forest Investigative Site 3726

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Arkansas

Fayetteville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Hot Springs : Forest Investigative Site 4009

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Little Rock : Forest Investigative Site 3837

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Little Rock : Forest Investigative Site 3810

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

California

Fullerton : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Los Angeles : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Paramount : Center for Clinical Trials, LLC

Attention Smokers and Ex-Smokers Clinical Research Study Participants Needed

San Diego : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

San Diego : Encompass Clinical Research

Do you have breathing problems?

Spring Valley : Encompass Clinical Research

Do you have breathing problems?

Spring Valley : Encompass Clinical Research

Has a long history of smoking left you breathless?

Anaheim : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Buena Park : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Cerritos : Forest Investigative Site 3750

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Costa Mesa : Forest Investigative Site 3898

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

El Cajon :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Encinitas : Forest Investigative Site 2402

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Fountain Valley : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Fountain Valley : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Fullerton : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Fullerton : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Garden Grove : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Gold River : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Gold River : Forest Investigative Site 3410

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Huntington Beach : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Huntington Beach : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Huntington beach : Forest Investigative Site 4022

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Huntington Park : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Laguna Hills : Forest Investigative Site 3866

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lakewood : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Lakewood : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Lancaster : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Lincoln : Forest Investigative Site 3415

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Loma Linda : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Lomita : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Long Beach : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Long Beach : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Los Angeles : University of California at Los Angeles Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Los Angeles : Cedars Sinai Medical Center

A clinical trial seeking patients for a research study for the treatment of Emphysema

Los Angeles : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Los Angeles : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Los Angeles : UCLA

Patients are needed to participate in a clinical research study evaluating Nebulized arformoterol and Salmeterol for the treatment of Chronic Obstructive Pulmonary Disease, COPD, Emphysema or Chronic Bronchitis

Los Angeles : Forest Investigative Site 3757

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Los Angeles : Forest Investigative Site 3471

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Mission Hills : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Mission Hills : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Mission Viejo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Montclair : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Montclair : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Monterey Park : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Mountain View : El Camino Hospital/Palo Alto Medical Foundation

A clinical trial seeking patients for a research study for the treatment of Emphysema

Newport Beach : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Newport Beach : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Northridge : Forest Investigative Site 3930

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Northridge : Forest Investigative Site 3720

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oceanside : Tri-City Pulmonary Medical Group

A clinical research study for the treatment of COPD

Orange : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Orangevale : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Oxnard : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Palm Springs : Forest Investigative Site 3727

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Palmdale : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Palo Alto : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Paramount : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Paramount : Forest Investigative Site 3087

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pasadena : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pismo Beach : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pismo Beach : Forest Investigative Site 3686

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Port Hueneme : Forest Investigative Site 3861

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Poway : Forest Investigative Site 3751

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rancho Mirage : California Stem Cell Treatment Center

A clinical trial to evaluate treatments using Administration of autologous adipose derived SVF

Rancho Mirage : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Rialto : Forest Investigative Site 3952

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Riverside : Kaiser Permanente Riverside Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Riverside : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Riverside : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Riverside : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Riverside : Forest Investigative Site 2399

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Roseville : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Roseville : Forest Investigative Site 3973

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sacramento : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sacramento : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sacramento : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sacramento : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sacramento : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sacramento : Forest Investigative Site 3083

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sacramento : Forest Investigative Site 3806

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

San Diego :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

San Diego :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

San Diego : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

San Diego : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

San Diego : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Diego : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Diego : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Diego : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Diego : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Diego : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

San Diego : Forest Investigative Site 2345

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

San Diego : Forest Investigative Site 3707

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

San Diego : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

San Francisco : Forest Investigative Site 3970

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

San Gabriel : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Jose : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Jose : Forest Investigative Site 3971

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Santa Ana : Forest Investigative Site 4035

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Santa Monica : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Santa Monica : Forest Investigative Site 3890

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Santa Monica : Forest Investigative Site 3964

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sepulveda : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sepulveda : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Stockton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Stockton : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Stockton : Forest Investigative Site 3749

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Torrance : Novartis Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Torrance : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Torrance : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Torrance : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Torrance : Harbor UCLA Medical Center

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Valencia : Sanguine Biosciences

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Van Nuys : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Ventura : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Vista : Cardinal Medical Group

A clinical research study for the treatment of COPD

Vista : Forest Investigative Site 3427

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Walnut Creek : Forest Investigative Site 2378

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

West Covina : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Westminster : Pathway Medical Group

A clinical research study for the treatment of COPD

Whittier : Forest Investigative Site 3719

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Whittier : Forest Investigative Site 3943

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wildomar : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Wildomar : Forest Investigative Site 3977

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Colorado

Wheat Ridge : Western States Clinical Research, Inc.

Attention Smokers or Ex-Smokers!

Boulder : Forest Investigative Site 3150

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Centennial : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Centennial : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Colorado Springs : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Colorado Springs : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Colorado Springs : Forest Investigative Site 2707

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Colorado Springs : Forest Investigative Site 3944

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Denver : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Denver : National Jewish Health

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Fort Collins : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Fort Collins : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Golden : Forest Investigative Site 2993

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Northglenn : Forest Investigative Site 3716

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wheat Ridge : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Wheat Ridge : 1237.25.10504 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Wheat Ridge : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Connecticut

Bristol : Forest Investigative Site 3959

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Danbury : 1012.65.00001 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study evaluating Combivent Respimat via ventilator adapter for the treatment of Pulmonary Disease, Chronic Obstructive

Glastonbury : Novartis Investigative Site

A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Hartford : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

New Haven : Yale University School of Medicine - Yale New Haven Hospital

A clinical trial seeking patients for a research study for the treatment of Emphysema

Stamford : 1237.26.10618 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Stamford : Novartis Investigative Site

A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Stamford : Forest Investigative Site 3151

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Waterbury : Novartis Investigative Site

A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Waterbury : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Waterbury : Forest Investigative Site 2461

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Waterbury : Forest Investigative Site 3519

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Delaware

Newark : Christiana Care Health System

A clinical trial to evaluate treatments for patients with Dyspnea

Wilmington : Forest Investigative Site 3746

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Florida

Clearwater : Clinical Research of West Florida

Do you have a chronic cough, shortness of breath, or difficulty breathing? Have you been diagnosed with chronic bronchitis, emphysema, or Chronic Obstructive Pulmonary Disease (COPD)?

Clearwater : Clinical Research of West Florida

Do you have COPD, Emphysema or Chronic Bronchitis?

Deland : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Fort Lauderdale : M & O Clinical Research

Diabetes with Asthma or COPD?

Kissimmee : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Ormond Beach : Peninsula Research

A 24 week study for patients who suffer from Chronic Obstructive Pulmonary Disease (COPD) due to current or prior history of smoking. Study Medication, Medical Care, Compensation may be provided to patients who qualify.

Ormond Beach : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Ormond Beach : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Palm Harbor : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Panama City : Emerald Coast Research Associates

Research Study for Chronic Obstructive Pulmonary Disease

Panama City : Emerald Coast Research Associates

Research Study for Chronic Obstructive Pulmonary Disease (COPD)

Pensacola : Pensacola Research Consultants Inc.

A Phase 3 clinical study for patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).

Pensacola : Pensacola Research Consultants Inc.

A Phase 4 clinical study for patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) who experience COPD exacerbations.

Tamarac : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Tamarac : Central Medical Group, P.A Research

Have you been diagnosed with COPD ?

Tamarac : Central Medical Group, P.A Research

Have you been diagnosed with COPD? We are seeking participants who are currently taking Advair or Symbicort on a daily basis to evaluate an investigational medication for COPD

Tampa : Clinical Research of West Florida

Are you a current or former smoker?

Bay Pines : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Boynton Beach : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Boynton Beach : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Brandon : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Brandon : Forest Investigative Site 3733

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Brandon : Forest Investigative Site 3487

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Brandon : Forest Investigative Site 2722

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Celebration : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Chiefland : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Clearwater : 1237.26.10619 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Clearwater : Bay Area Chest Physicians

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Clearwater :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Clearwater : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Clearwater : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Clearwater : 1237.25.10507 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Clearwater : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Clearwater : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Clearwater : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Clearwater : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Clearwater : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Clearwater : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Clearwater : Forest Investigative Site 3811

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Clearwater : Forest Investigative Site 2721

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Clearwater : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Coral Gables : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Coral Gables : Forest Investigative Site 3834

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Crystal River : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Daytona Beach : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Daytona Beach : Forest Investigative Site 3945

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Debary : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Debary : Forest Investigative Site 3500

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

DeLand : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Deland : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

DeLand : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

DeLand : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Deland : Forest Investigative Site 3990

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Delray Beach : Forest Investigative Site 3859

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Doral : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Edgewater : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Fleming Island : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Fort Lauderdale : Gary J. Richmond, MD, PA

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Fort Lauderdale :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Fort Lauderdale : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Fort Lauderdale : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Gainesville : University of Florida

A clinical trial seeking patients for a research study for the treatment of Emphysema

Gainesville : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Gainesville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Hialeah : Novartis Investigative Site

A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Hialeah :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Hialeah : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Hialeah : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Hialeah : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Hialeah : Forest Investigative Site 3897

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 3947

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 4029

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 3863

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 3992

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 3068

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hollywood :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Hollywood : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Hollywood : Forest Investigative Site 2960

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Jacksonville : Mayo Clinic Jacksonville Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Jacksonville : University of Florida, Jacksonville

A clinical trial seeking patients for a research study for the treatment of Pulmonary Arterial Hypertension or Chronic Obstructive Pulmonary Disease

Jacksonville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Jacksonville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Jacksonville : Forest Investigative Site 3818

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Jupiter : Forest Investigative Site 3804

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kissimmee : Pulmonary Disease Specialists PA

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Kissimmee : Pulmonary Disease Specialist/PDS Research

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Kissimmee : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Kissimmee : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Kissimmee : Forest Investigative Site 3783

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kissimmee : Forest Investigative Site 3833

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kissimmee : Forest Investigative Site 475

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kissimmee : Forest Investigative Site 3000

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lehigh Acres : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Lynn Haven : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Maitland : Forest Investigative Site 3664

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Melbourne : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Melbourne : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Melbourne : Forest Investigative Site 3955

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : IMIC, Inc.

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Miami : San Marcus Research Clinic Inc.

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Miami : South Florida Research Phase I-IV

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Miami : Elite Clinical Research

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Miami : Novartis Investigative Site

A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Miami : Novartis Investigative Site

A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Miami : Novartis Investigative Site

A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Miami : Armando Pineda Velez

A clinical trial to evaluate treatments using Adipose Derived Stem Cells for patients with Chronic Obstructive Pulmonary Disease

Miami :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Miami :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Miami :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Miami :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Miami : Well Pharma Medical Research

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Miami : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Miami : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Miami : Ageless Institute

Patients are needed to participate in a clinical research study evaluating Adipose-Derived Stem Cell (ADSC) Therapy for the treatment of Chronic Obstructive Pulmonary Disease

Miami : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Miami : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Miami : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Miami : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Miami : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Miami : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Miami : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Miami : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Miami : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Miami : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Miami : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Miami : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Miami : Forest Investigative Site 3978

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3928

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3921

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3950

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 4023

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3948

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3795

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3790

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3918

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3938

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3844

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3724

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3942

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3424

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Advanced Pharma CR, LLC Updated

Patients are needed to participate in a clinical research study of GS-5745 and Placebo to match GS-5745 to evaluate Chronic Obstructive Pulmonary Disease

Miami : Elite Research Institute Updated

Patients are needed to participate in a clinical research study of GS-5745 and Placebo to match GS-5745 to evaluate Chronic Obstructive Pulmonary Disease

Miami Beach :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Miami Beach : Forest Investigative Site 3872

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miramar : Forest Investigative Site 3758

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Naples : Forest Investigative Site 3362

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Port Richey : Advanced Research Institute, Inc.

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

New Port Richey :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

New Port Richey : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

New Port Richey : Forest Investigative Site 3761

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Ocala : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Ocala : Forest Investigative Site 3794

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Ocala : Forest Investigative Site 4033

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Orlando : Florida Hospital Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Orlando : Central Florida Pulmonary Group, P.A.

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Orlando :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Orlando : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Orlando : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Orlando : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Orlando : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Orlando : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Orlando : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Orlando : Forest Investigative Site 3111

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Orlando : Compass Research, LLC Updated

Patients are needed to participate in a clinical research study of GS-5745 and Placebo to match GS-5745 to evaluate Chronic Obstructive Pulmonary Disease

Ormond Beach : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Ormond Beach : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Ormond Beach : Forest Investigative Site 2714

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oviedo : Forest Investigative Site 3693

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Palm Harbor :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Palm Harbor : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Panama City : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Panama City : 1237.25.10517 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Panama City : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Pembroke Pines : Forest Investigative Site 3925

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pensacola : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Pensacola : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Pensacola : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pensacola : Forest Investigative Site 2536

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pinellas Park : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Port Orange : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Port Orange : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Port Orange : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Port Orange : Forest Investigative Site 2954

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sanford : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Sarasota : Sarasota Memorial Hospital Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Sarasota : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sarasota : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sarasota : Forest Investigative Site 3360

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sebring : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Sebring : Forest Investigative Site 4042

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Seminole : Forest Investigative Site 3858

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

South Miami : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

St. Petersburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

St. Petersburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

St. Petersburg : Forest Investigative Site 4028

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Petersburg : Forest Investigative Site 3807

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Petersburg : Forest Investigative Site 3645

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Petersburg : Forest Investigative Site 3426

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Summerfield : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Tamarac : Concept Clinical Trials, LLC

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Tamarac : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tamarac : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Tamarac : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Tamarac : Forest Investigative Site 2417

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tampa : 1237.26.10614 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Tampa : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tampa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Tampa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Tampa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Tampa : Forest Investigative Site 2386

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Trinity : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Vero Beach : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Wellington : Axcess Medical Research

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Wellington : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Winter Park : Florida Premier Research Institute

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Winter Park : Florida Premier Research Institute

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Winter Park : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Winter Park : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Winter Park : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Winter Park : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Winter Park : Forest Investigative Site 3988

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winter Park : Forest Investigative Site 2751

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winter Park : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Zephyrhills : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Georgia

Atlanta : NeuroTrials Research Updated

Breathe New Life into COPD Research!

Blue Ridge : River Birch Research Alliance, LLC

COPD (Chronic Obstructive Pulmonary Disease)

Columbus : Columbus Regional Research Institute

Chronic Obstructive Pulmonary Disease which includes chronic bronchitis and emphysema

Columbus : Columbus Regional Research Institute

Do you have COPD, Emphysema or Chronic Bronchitis?

Duluth : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Lawrenceville : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Atlanta : Piedmont Hospital Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Atlanta :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Atlanta : Forest Investigative Site 2542

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Atlanta : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Austell : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Blue Ridge : River Birch Research Alliance LLC

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Blue Ridge : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Blue Ridge : Forest Investigative Site 2746

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Canton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Columbus : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Columbus : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Cumming : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Decatur : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Duluth : 1237.26.10616 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Duluth : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Gainesville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Johns Creek : Forest Investigative Site 3869

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lawrenceville : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Lawrenceville : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Marietta : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Marietta : Forest Investigative Site 3669

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Norcross : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Norcross : Forest Investigative Site 3868

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oakwood : Forest Investigative Site 3747

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Roswell :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Savannah : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Savannah : Forest Investigative Site 3989

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Snellville : Forest Investigative Site 3832

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Snellville : Forest Investigative Site 3672

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Stockbridge : Forest Investigative Site 4045

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Woodstock : Forest Investigative Site 2424

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hawaii

Honolulu : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Idaho

Coeur d'Alene : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Coeur d'Alene : 1237.25.10505 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Coeur d'Alene : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Coeur d'Alene : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Coeur d'Alene : Forest Investigative Site 2666

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Eagle : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Eagle : Forest Investigative Site 3400

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hayden Lake : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Hayden Lake : Forest Investigative Site 3839

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Idaho Falls : Forest Investigative Site 3979

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Idaho Falls : Forest Investigative Site 3913

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Idaho Falls : Forest Investigative Site 3812

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Meridian : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Meridian : Forest Investigative Site 3755

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Illinois

Skokie : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Aurora : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Burr Ridge : Forest Investigative Site 3725

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Champaign : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Chicago : University of Chicago Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Chicago : University of Illinois Hospital and Health Center

A clinical trial seeking patients for a research study for the treatment of Emphysema

Chicago : Northwestern University

A clinical trial seeking patients for a research study for the treatment of Emphysema

Chicago : University of Chicago Medical Center

A clinical trial to evaluate treatments using Placebo and Nebivolol for patients with High Blood Pressure

Chicago :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Chicago :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Chicago : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Chicago : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Elk Grove Village : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Evergreen Park : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Gillespie : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Gillespie : Forest Investigative Site 3784

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Morton : Forest Investigative Site 3680

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Normal : Novartis Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Normal : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Normal : Forest Investigative Site 3651

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oak Lawn : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

O'Fallon : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

O'Fallon : Forest Investigative Site 2967

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Peoria : Illinois Lung and Critical Care Institute

A clinical trial seeking patients for a research study for the treatment of Emphysema

Peoria : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Peoria : Forest Investigative Site 3908

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Peoria : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

River Forest : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

River Forest : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Skokie : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Indiana

Anderson : Community Clinical Research Center

A Randomized, Double-Blind (Test Products and Placebo), Chronic Dosing (24 Weeks), Placebo-Controlled, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD, Compared With Placebo and Spiriva® Handihaler® (Tiotropium Bromide 18 µg, Open-Label) as an Active Control

Avon : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Avon : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Avon : Forest Investigative Site 3709

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Evansville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Evansville : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Franklin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Franklin : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Greenfield : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Indianapolis : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Lafayette : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Michigan City : Forest Investigative Site 3789

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Muncie : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Muncie : Forest Investigative Site 3756

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Muncie : Forest Investigative Site 3656

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

South Bend : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Valparaiso : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Valparaiso : Forest Investigative Site 3966

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Iowa

Ames : Forest Investigative Site 3936

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Council Bluffs : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Council Bluffs : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Iowa City : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Iowa City : University of Iowa

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Iowa City : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

West Des Moines : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Kansas

Kansas City : Forest Investigative Site 3702

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lenexa : Forest Investigative Site 3855

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Newton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Olathe : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pratt : Forest Investigative Site 3999

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Topeka : Veritas Clinical Specialties, Ltd

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Topeka : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Topeka : Forest Investigative Site 2634

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Topeka : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Wichita : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Kentucky

Lexington : Kentucky Medical Research

COPD Moderate to Severe

Bowling Green : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Bowling Green : Forest Investigative Site 2372

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Crestview Hills : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Elizabethtown : Forest Investigative Site 3828

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hawesville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Hazard : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Hazard : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Lexington : University of Kentucky

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease (COPD)

Lexington : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Lexington : Forest Investigative Site 3856

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Louisville : Kentucky Research Group

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Louisville : University of Louisville, Pulmonary Division

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Louisville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Louisville : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Louisville : Forest Investigative Site 3045

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Madisonville : Forest Investigative Site 3933

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Louisiana

Covington : Forest Investigative Site 3881

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Eunice : Forest Investigative Site 3793

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lafayette : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Lafayette : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Metairie : MedPharmics LLC

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Metairie : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Metairie : Forest Investigative Site 3880

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Orleans : Forest Investigative Site 3878

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Opelousas : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Opelousas : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Opelousas : Forest Investigative Site 3355

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Shreveport : Forest Investigative Site 3961

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Slidell : Forest Investigative Site 3661

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sunset : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Zachary : Forest Investigative Site 3800

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Maine

Auburn : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Bangor : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Bangor : Forest Investigative Site 3357

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Biddeford : Novartis Investigative Site

A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Biddeford : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Biddeford : Forest Investigative Site 3886

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Maryland

Baltimore : University of Maryland Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Baltimore : Pulmonary and Critical Care Associates of Baltimore

A clinical trial seeking patients for a research study for the treatment of Emphysema

Baltimore : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Baltimore : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Baltimore : Pearl Investigative Siteq Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Baltimore : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating GSK2256294 for the treatment of Pulmonary Disease, Chronic Obstructive

Baltimore : Forest Investigative Site 3025

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Bethesda : Walter Reed National Military Medical Center

A clinical trial seeking patients for a research study for the treatment of Emphysema

Columbia : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Columbia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Columbia : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Elkridge : Forest Investigative Site 3689

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Elkton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Hagerstown : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Hollywood : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Oxon Hill : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Towson : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Towson : Forest Investigative Site 3670

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Towson : Forest Investigative Site 3883

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Massachusetts

Fall River : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Methuen : ActivMed Practices & Research, Inc. Updated

Do You Have COPD, Emphysema or Chronic Bronchitis??

Boston : Beth Israel Deaconess Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Boston : Beth Israel Deaconess Medical Center

A clinical trial seeking patients for a research study for the treatment of Emphysema

Boston : Brigham and Women's Hospital

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Brockton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Burlington : Lahey Clinic Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Fall River : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Fall River : Forest Investigative Site 3124

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Haverhill : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

N. Dartmouth : Forest Investigative Site 2549

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

North Dartmouth : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

North Dartmouth : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Waltham :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Waltham : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Michigan

Ann Arbor : ClinSite, LLC

Diagnosed with COPD, Chronic Bronchitis or Emphysema?

Bingham Farms : QUEST Research Institute

Chronic Obstructive Pulmonary Disease Study

Ann Arbor : University of Michigan Health System

A clinical trial seeking patients for a research study for the treatment of Emphysema

Ann Arbor : University of Michigan Health System

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease (COPD)

Ann Arbor : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Ann Arbor : 1237.25.10516 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Ann Arbor : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Bingham Farms : Forest Investigative Site 4018

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Buckley : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Buckley : Forest Investigative Site 4013

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Chesterfield : Forest Investigative Site 3969

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Clinton Township : Forest Investigative Site 3899

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Detroit : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Flint :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Kalamazoo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Livonia : 1237.25.10509 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Livonia : Forest Investigative Site 2498

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Royal Oak : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Southfield : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Stevensville : Forest Investigative Site 3035

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Traverse City : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Traverse City : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Traverse City : Forest Investigative Site 3156

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Troy : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Troy : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Minnesota

Minneapolis : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Plymouth : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Eagan :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Edina : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Edina : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Edina : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Fridley : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Fridley : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Minneapolis : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Minneapolis : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Minneapolis : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Minneapolis : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Minneapolis : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Minneapolis : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Minneapolis : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Minneapolis : Forest Investigative Site 2381

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Minneapolis : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Plymouth : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Rochester : Mayo Clinic

A clinical trial seeking patients for a research study for the treatment of Emphysema

Rochester : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Rochester : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Rochester : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Woodbury : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Mississippi

Biloxi : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Missouri

St. Charles : Midwest Chest Consultants, PC

Midwest Chest Consultants, located in St. Charles Missouri, is currently conducting a research study with individuals with Chronic Obstructive Pulmonary Disease (COPD).

St. Charles : Midwest Chest Consultants, PC

Midwest Chest Consultants, located in St. Charles Missouri, is currently conducting a research study with individuals with Chronic Obstructive Pulmonary Disease (COPD). We are evaluating a study medication compared to placebo on arterial stiffness.

St. Louis : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

St. Louis : Midwest Clinical Research LLC

Are you a current or former smoker? Do you have a diagnosis of Chronic Obstructive Pulmonary Disease or COPD?

St. Louis : The Clinical Research Center, LLC

Do you experience a productive cough at least 4 months out of the year and take medication to treat your symptoms? Is so you may qualify for a COPD research study.

St. Louis : The Clinical Research Center, LLC

Have you been diagnosed with COPD and struggle with shortness of breath symptoms? If so, you may qualify for clinical trial.

St. Louis : The Clinical Research Center, LLC

The Clinical Research Center is looking for patients with uncontrolled Diabetes who have also been diagnosed with either Asthma or COPD to test an investigational medication for diabetes.

Chesterfield : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Kansas City : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Kansas City : Forest Investigative Site 3154

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Springfield : Forest Investigative Site 3411

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Charles : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

St. Charles : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

St. Charles : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

St. Charles : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

St. Louis : 1237.26.10613 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

St. Louis : Washington University in St. Louis

A clinical research study of HXe MRI lung ventilation for the treatment of Asthma, COPD or Healthy

St. Louis :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

St. Louis : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

St. Louis : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

St. Louis : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

St. Louis : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

St. Louis : Forest Investigative Site 3028

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Louis : Forest Investigative Site 3799

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Louis : Forest Investigative Site 2956

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Louis : Forest Investigative Site 3696

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Louis : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

St. Louis : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

St. Peters :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

St.Charles : Forest Investigative Site 2413

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Montana

Billings : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Missoula : Montana Medical Research, Inc.

Do You Have COPD, Emphysema or Chronic Bronchitis?

Billings : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Billings : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Butte : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Missoula : Novartis Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Missoula : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Missoula : Forest Investigative Site 2957

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Nebraska

OMAHA : QUALITY CLINICAL RESEARCH

Chronic Obstructive Pulmonary Disease (COPD)

Bellevue : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Bellevue : Forest Investigative Site 2972

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Bellevue : Forest Investigative Site 3808

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Fremont : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Fremont : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Fremont : Forest Investigative Site 3873

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Grand Island : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Grand Island : Forest Investigative Site 3910

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lincoln : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Lincoln : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Lincoln : Forest Investigative Site 3167

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lincoln : Forest Investigative Site 3358

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lincoln : Forest Investigative Site 3896

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Omaha : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Omaha : UNMC College of Medicine

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease (COPD)

Omaha :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Omaha : University of Nebraska Medical Center

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Omaha : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Omaha : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Omaha : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Omaha : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Omaha : Forest Investigative Site 4002

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Omaha : Forest Investigative Site 3451

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Omaha : Forest Investigative Site 2982

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Omaha : Forest Investigative Site 3653

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Omaha : University of Nebraska Medical Center

Patients are needed to participate in a clinical research study to evaluate COPD

Papillion : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Papillion : Forest Investigative Site 3997

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Papillion : Forest Investigative Site 3877

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Nevada

Las Vegas : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Las Vegas : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Henderson : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Henderson : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Henderson : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Las Vegas : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Las Vegas : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Las Vegas : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Las Vegas : Forest Investigative Site 2973

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Las Vegas : Forest Investigative Site 3779

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Las Vegas : Forest Investigative Site 3874

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Las Vegas : Forest Investigative Site 3906

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Reno : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

New Hampshire

Newington : ActivMed Practices & Research, Inc. NH Updated

Do You Have COPD, Emphysema or Chronic Bronchitis?

Lebanon : Novartis Investigative Site

A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Lebanon : Dartmouth-Hitchcock Medical Center

Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease

Newington : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

New Jersey

Linden : Biomedical Research Alliance of New York

Chronic Obstructive Pulmonary Disease (COPD) and a history of or at risk for cardiovascular disease - Adults

Brandon : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Cedar Knolls : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

E. Brunswick : Forest Investigative Site 3835

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Elizabeth : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Elizabeth : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Elizabeth : Forest Investigative Site 3932

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Freehold : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Haddon Heights : Forest Investigative Site 3674

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Linden : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Lodi : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Marlton : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Ocean : Forest Investigative Site 2944

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Summit : Forest Investigative Site 2418

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Toms River : Forest Investigative Site 3743

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Warren : Forest Investigative Site 3902

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Mexico

Albuquerque : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Albuquerque : Forest Investigative Site 2393

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New York

Elmira : Health Sciences Research Center

Attention Smokers and Ex-smokers. Do you have trouble breathing or a persistent cough?

Endwell : Regional Clinical Research, Inc.

A national study for people with shortness of breath and other respiratory problems.

Endwell : Regional Clinical Research, Inc.

Do you have any of these problems? Shortness of Breath? Cough? Chronic Bronchitis? Emphysema? Wheezing? Phlegm? Chronic Obstructive Pulmonary Disease?

Rochester : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Rochester : AAIR Research Center

If you or a loved one has Chronic Obstructive Pulmonary Disease (COPD), you may be interested in this clinical research study.

Rochester : AAIR Research Center

PT003007 COPD Study

Albany : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Bayside :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Bronx : Lincoln Medical and Mental Health Center

A clinical trial to evaluate treatments for patients with Dyspnea

Bronx : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Bronx : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Bronxville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Brooklyn : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Brooklyn : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Brooklyn : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Brooklyn : Forest Investigative Site 2532

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Corning : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Forest Hills : Forest Investigative Site 3843

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Great Neck : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Great Neck : Forest Investigative Site 2720

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Hyde Park : Forest Investigative Site 3851

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Windsor : Forest Investigative Site 3110

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New York : New York Presbyterian Columbia University Medical Center

A clinical trial seeking patients for a research study for the treatment of Emphysema

New York : Columbia University Medical center / New York Presbyterian Hospital

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease (COPD)

New York : Mount Sinai School of Medicine

A clinical trial to evaluate treatments for patients with Dyspnea

New York :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

New York : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

New York : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

New York : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

New York : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

New York : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

New York : Forest Investigative Site 3782

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rochester : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Rochester : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Syracuse : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Syracuse : Forest Investigative Site 3118

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Westfield : Forest Investigative Site 3671

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

North Carolina

Boone : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Hendersonville : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Huntersville : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Salisbury : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Wilmington : PMG Research of Wilmington

COPD- Chronic Obstructive Pulmonary Disease Makes It Harder to Breathe

Wilmington : PMG Research of Wilmington

If you have Chronic Obstructive Pulmonary Disease (COPD), you need to know about Alpha-1 Antitrypsin Deficiency.

Asheville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Asheville : Forest Investigative Site 3658

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Calabash : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Chapel Hill :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Chapel Hill : UNC-Chapel Hill

Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability

Charlotte : Carolinas Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Charlotte : American Health Research

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Charlotte :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Charlotte : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Charlotte : 1237.25.10519 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Charlotte : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Charlotte : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Charlotte : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Charlotte : Forest Investigative Site 3965

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charlotte : Forest Investigative Site 3909

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charlotte : Forest Investigative Site 3768

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charlotte : Forest Investigative Site 3091

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charlotte : Forest Investigative Site 3785

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charlotte : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Durham : Duke University Medical Center

A clinical trial seeking patients for a research study for the treatment of Emphysema

Elizabeth City : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Greensboro : 1237.26.10615 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Greensboro : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Greensboro : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Greensboro : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Greensboro : Forest Investigative Site 3983

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Greenville :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Greenville : Forest Investigative Site 3923

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hendersonville : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

High Point : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

High Point : Forest Investigative Site 3903

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Huntersville : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Huntersville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Huntersville : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Knightdale : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Lenoir : Forest Investigative Site 3736

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Mooresville : Forest Investigative Site 3688

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Morehead City :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Morganton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Raleigh : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Raleigh : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Salisbury : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Salisbury : Forest Investigative Site 3889

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sanford : Forest Investigative Site 3694

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Shelby : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Shelby : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Shelby : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Shelby : Forest Investigative Site 3142

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Statesville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Stateville : Forest Investigative Site 2953

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wilmington : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Wilmington : Forest Investigative Site 3109

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winston-Salem : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Winston-Salem : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Winston-Salem : Wake Forest University Baptist Medical Center

Patients are needed to participate in a clinical research study evaluating NIOX MINO® for the treatment of Chronic Obstructive Pulmonary Disease

Winston-Salem : Forest Investigative Site 3796

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winston-Salem : Forest Investigative Site 3786

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winston-Salem : Forest Investigative Site 4019

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winston-Salem : Forest Investigative Site 3791

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

North Dakota

Fargo : Forest Investigative Site 3687

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Ohio

Columbus : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Kettering : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Willoughby : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Akron : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Canton : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Canton : Forest Investigative Site 2704

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Cincinnati : University of Cincinnati Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Cincinnati :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Cincinnati : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Cincinnati : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Cincinnati : 1237.25.10503 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Cincinnati : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Cincinnati : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Cincinnati : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Cincinnati : Forest Investigative Site 2343

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Cincinnati : Forest Investigative Site 4007

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Cincinnati : Forest Investigative Site 3780

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Cleveland : University Hospitals Case Medical Center

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Cleveland : The Cleveland Clinic

A clinical trial seeking patients for a research study for the treatment of Emphysema

Cleveland : Metrohealth Medical Center

A clinical trial to evaluate treatments for patients with Dyspnea

Cleveland : The Cleveland Clinic

Evaluation of ST2 and IL-33 in Patients Presenting to the Emergency Department With Trouble Breathing

Cleveland : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Columbia : 1237.25.10518 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Columbus : 1237.26.10603 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Columbus : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Columbus : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Columbus : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Columbus : 1237.25.10502 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Columbus : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Columbus : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Columbus : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Columbus : Forest Investigative Site 2980

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dayton : 1237.26.10621 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Dayton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Dayton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Dayton : Forest Investigative Site 3655

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dayton : Forest Investigative Site 3648

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Delaware : Forest Investigative Site 3708

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dublin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Dublin : 1237.25.10511 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Dublin : Forest Investigative Site 3665

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Marion : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Marion : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Maumee : Forest Investigative Site 3710

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miamisburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Norwood : Forest Investigative Site 3972

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sylvania : Forest Investigative Site 2425

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Toledo : 1237.26.10612 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Toledo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Toledo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Toledo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Toledo : Forest Investigative Site 3646

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Toledo : Forest Investigative Site 3713

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wooster : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Oklahoma

Norman : Forest Investigative Site 3691

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oklahoma City : 1237.26.10605 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Oklahoma City : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Oklahoma City : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Oklahoma City : Forest Investigative Site 3695

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oklahoma City : Forest Investigative Site 3699

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oklahoma City : Forest Investigative Site 3654

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tulsa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Tulsa : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Tulsa : Forest Investigative Site 4027

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tulsa : Forest Investigative Site 4025

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oregon

Medford : Sunstone Medical Research, LLC

Seeking past or current smokers with COPD (Chronic Obstructive Pulmonary Disease) also known as emphysema or chronic bronchitis, to participant in a 9 week long clinical research study.

Medford : Sunstone Medical Research, LLC

Seeking past or current smokers with COPD (Chronic Obstructive Pulmonary Disease) also known as emphysema or chronic bronchitis, to participant in a Clinical Research Study.

Medford : Sunstone Medical Research, LLC

Seeking past or current smokers with severe COPD (Chronic Obstructive Pulmonary Disease) also known as emphysema or chronic bronchitis, to participant in a Clinical Research Study.

Bend : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Bend : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Clackamas : Kaiser Permanente Northwest Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Medford : 1237.26.10606 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Medford :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Medford : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Portland : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Portland : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Portland : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Portland : Forest Investigative Site 3766

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Springfield : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pennsylvania

Bethlehem Township : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Uniontown : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Abington : Forest Investigative Site 3723

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Altoona : Forest Investigative Site 3935

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Beaver : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Beaver : Forest Investigative Site 3650

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Belle Vernon : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Carnegie : Forest Investigative Site 3681

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Clairton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Clairton : Forest Investigative Site 4000

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Downingtown : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Downingtown : Forest Investigative Site 3363

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Doylestown : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Erie : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Erie : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Erie : Forest Investigative Site 2352

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Fleetwood : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Harleysville : Forest Investigative Site 3692

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Harleysville : Forest Investigative Site 3957

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hershey : Penn State Milton S. Hershey Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Hershey : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Langhorne : Forest Investigative Site 3745

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Monroeville : Forest Investigative Site 3685

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Penndel : Forest Investigative Site 3690

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Perryopolis : Forest Investigative Site 3774

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Perryopolis : Forest Investigative Site 3801

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Philadelphia : University of Pennsylvania Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Philadelphia : Temple Lung Center Pulmonary & Critical Care Medicine

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Philadelphia : Temple

A clinical trial seeking patients for a research study for the treatment of Emphysema

Philadelphia : Pennsylvania Hospital

A clinical trial to evaluate treatments for patients with Dyspnea

Philadelphia : Temple University Hospital

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Philadelphia : 1237.25.10514 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Philadelphia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Philadelphia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Philadelphia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Philadelphia : Temple University Medical Center

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Phoenixville : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Pittsburgh : Emphysema COPD Research Center, University of Pittsburgh

A clinical trial seeking patients for a research study for the treatment of Emphysema

Pittsburgh : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Pittsburgh : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Pittsburgh : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Pittsburgh : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Pittsburgh : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pittsburgh : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pittsburgh : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pittsburgh : Forest Investigative Site 2715

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pittsburgh : Forest Investigative Site 3115

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Scottdale : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Scranton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Smithfield : Forest Investigative Site 3704

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tipton : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tipton : Forest Investigative Site 3016

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Uniontown : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Uniontown : Forest Investigative Site 3684

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Uniontown : Forest Investigative Site 3119

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Uniontown : Forest Investigative Site 3659

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Upper St. Clair : Forest Investigative Site 3885

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Warminster : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Warminster : Forest Investigative Site 3676

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wyomissing : Forest Investigative Site 3941

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rhode Island

East Greenwich : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

East Greenwich : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Johnston : Clinical Partners, LLC

Chronic Bronchitis or Emphysema-also known as Chronic Obstructive Pulmonary Disease which is most often caused by cigarette smoking.

East Providence : 1237.26.10610 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

East Providence : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

East Providence : Forest Investigative Site 2678

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Johnston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Warwick : Novartis Investigative Site

A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

South Carolina

Anderson : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Anderson : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Easley : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Fort Mill : Piedmont Research Partners, LLC New

Double-blind, randomized, placebo-controlled, parallel-group, phase IV study to evaluate the effect of Aclidinium Bromide on long-term cardiovascular safety and COPD exacerbations in patients with moderate to severe COPD

Gaffney : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Mt. Pleasant : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Rock Hill : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Rock Hill : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Spartanburg : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Spartanburg : Spartanburg Medical Research

Double-Blind study evaluating the effect of Fluticasone Furoate/Vilanterol Inhalation powder once daily comparted with Vilanterol Inhalation powder once daily on Bone Mineral Density in subjects with COPD.

Spartanburg : Spartanburg Medical Research

Inhaled Nitric Oxide/Inopulse® Ds-C Combination Product

Union : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Anderson : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Anderson : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Anderson : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Anderson : Forest Investigative Site 3817

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charleston : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Charleston : Medical University of South Carolina

A clinical trial seeking patients for a research study for the treatment of Emphysema

Charleston : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Charleston : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Charleston : 1237.25.10513 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Charleston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Charleston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Charleston : Forest Investigative Site 2407

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charleston : Forest Investigative Site 3647

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charleston : Forest Investigative Site 3344

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Columbia : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Columbia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Columbia : Forest Investigative Site 3697

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Easley : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Easley : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Easley : 1237.25.10515 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Easley : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Easley : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Florence : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Fort Mill : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Fort Mill : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Fort Mill : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Fort Mill : Forest Investigative Site 3456

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Gaffney : 1237.26.10607 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Gaffney : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Gaffney : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Gaffney : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Gaffney : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Gaffney : Forest Investigative Site 3455

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Gaffney : Forest Investigative Site 3742

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Gaffney : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Greenville : 1237.26.10617 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Greenville : Greenville Pharmaceutical Research

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Greenville : Chandar Abboy

A clinical research study of Peforomist-Placebo and Perforomist, nebulization, COPD for the treatment of COPD

Greenville : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Greenville :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Greenville : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Greenville : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Greenville : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Greenville : 1237.25.10506 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Greenville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Greenville : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Greenville : Forest Investigative Site 3700

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Greenville : Forest Investigative Site 3679

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Greenville : Forest Investigative Site 3865

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Greenwood : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Greer : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Hodges : Forest Investigative Site 3924

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Longs : Forest Investigative Site 3778

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Murrells Inlet : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Orangeburg : Forest Investigative Site 3976

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pelzer : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Pelzer : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pelzer : Forest Investigative Site 2670

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rock Hill : Clinical Research of Rock Hill

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Rock Hill : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Rock Hill :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Rock Hill : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Rock Hill : 1237.25.10501 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Rock Hill : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Rock Hill : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Seneca : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Seneca : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Simpsonville : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Spartanburg : 1237.26.10608 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Spartanburg : Spartanburg Medical Research

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Spartanburg : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Spartanburg :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Spartanburg :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Spartanburg :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Spartanburg : Novartis Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Spartanburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Spartanburg : 1237.25.10508 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Spartanburg : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Spartanburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Spartanburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Spartanburg : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Spartanburg : Forest Investigative Site 2691

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Spartanburg : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Summerville : Forest Investigative Site 3677

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Union : 1237.26.10604 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Union : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Union : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Union : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Union : Forest Investigative Site 3017

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Williamston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Williamston : Forest Investigative Site 3846

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

South Dakota

Dakota Dunes : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Rapid City : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Rapid City : Forest Investigative Site 2892

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rapid City : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Tennessee

Brentwood : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Bristol : PMG Research of Bristol

COPD- Chronic Obstructive Pulmonary Disease Makes It Harder to Breathe

Knoxville : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

New Tazewell : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Athens : Forest Investigative Site 3841

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Chattanooga : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Chattanooga : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Chattanooga : Forest Investigative Site 3857

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Fayetteville : Forest Investigative Site 3075

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Johnson City : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Johnson City : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Kingsport : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Knoxville : University of Tennessee Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Knoxville : Volunteer Research Group Updated

Patients are needed to participate in a clinical research study of GS-5745 and Placebo to match GS-5745 to evaluate Chronic Obstructive Pulmonary Disease

Nashville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Nashville : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Shelbyville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Shelbyville : Forest Investigative Site 3864

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Spring Hill : Forest Investigative Site 3919

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Texas

El Paso : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Houston : DM Clinical Research

Type 2 Diabetes- Houston,TX

Kingwood : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Lewisville : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Longview : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

San Antonio : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

San Antonio : Women's Diagnostics

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Lung Diagnostics, LTD

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Lung Diagnostics, LTD

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Diagnostics Research Group

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Allergy Diagnostics

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Women's Diagnostics

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Diagnostics Research Group

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Allergy Diagnostics

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Sun Research Institute

Do you smoke cigarettes? Do you suffer from COPD? You may qualify to participate in a study.

Amarillo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Amarillo : Forest Investigative Site 3777

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Arlington :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Arlington : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Arlington : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Arlington : Forest Investigative Site 3737

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Austin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Austin : Forest Investigative Site 0564

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Austin : Forest Investigative Site 3057

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Beaumont : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Boerne : 1237.26.10609 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Boerne : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Boerne : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Boerne : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Carrollton : Forest Investigative Site 3738

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Channelview : Forest Investigative Site 3962

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Corsicana : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Corsicana : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Corsicana : Forest Investigative Site 3359

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dallas : UT Southwestern Medical Center at Dallas Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Dallas :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Dallas :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Dallas :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Dallas : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Dallas : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Dallas : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Dallas : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Dallas : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Dallas : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Dallas : Forest Investigative Site 3435

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dallas : Forest Investigative Site 3798

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dickinson : Forest Investigative Site 3854

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Duncanville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Edinburg : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Edinburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

El Paso : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Fort Worth : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Fort Worth : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Fort Worth : 1012.65.00002 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study evaluating Combivent Respimat via ventilator adapter for the treatment of Pulmonary Disease, Chronic Obstructive

Fort Worth : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Fort Worth : Forest Investigative Site 3862

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Fort Worth : Forest Investigative Site 2348

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Frisco : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Georgetown : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Georgetown : Forest Investigative Site 3870

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Houston : Michael DeBakey VA Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Houston : Pulmonary, Critical Care & Sleep Medicine Consultants,PCCS/St. Luke's Episcopal Hospital

A clinical trial seeking patients for a research study for the treatment of Emphysema

Houston : DeBakey Medical Center - VA Houston

A clinical trial seeking patients for a research study for the treatment of Emphysema

Houston : Texas Institute of Chest and Sleep Disorders, PA

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Houston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Houston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Houston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Houston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Houston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Houston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Houston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Houston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Houston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Houston : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Houston : Forest Investigative Site 3929

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Houston : Forest Investigative Site 3871

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Houston : Forest Investigative Site 3991

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Houston : Forest Investigative Site 3922

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Huntsville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Irving : Forest Investigative Site 3714

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Irving : Forest Investigative Site 3937

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Irving : Forest Investigative Site 3995

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Killeen : 1237.25.10520 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Killeen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Kingwood : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Longview : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Lufkin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Lufkin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

McKinney : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

McKinney : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

McKinney : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

New Braunfels : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

North Richland Hills :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

North Richland Hills : Forest Investigative Site 3882

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

San Angelo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Antonio : 1237.26.10602 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

San Antonio : University of Texas Health Sciences Center at San Antonio

A clinical trial seeking patients for a research study for the treatment of Emphysema

San Antonio :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

San Antonio : Diagnostics Research Group

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

San Antonio : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

San Antonio : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

San Antonio : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Antonio : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Antonio : Forest Investigative Site 3894

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

San Antonio : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Sugar Land : Pioneer Research Solutions, Inc.

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Sugar Land : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sugar Land : Forest Investigative Site 3879

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sugar Land : Forest Investigative Site 3920

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sugar Land : Forest Investigative Site 3953

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sugar Land : Forest Investigative Site 3792

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Temple : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Tomball :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Tyler : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tyler : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Tyler : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Tyler : Forest Investigative Site 2703

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Victoria : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Waco : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Waco : Forest Investigative Site 3875

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Webster : Forest Investigative Site 3916

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Utah

Salt Lake City : Optimum Clinical Research, Inc.

COPD / Emphysema / Chronic Bronchitis caused by smoking.

Salt Lake City : Optimum Clinical Research, Inc.

COPD/Emphysema/Chronic Bronchitis

Ogden : Forest Investigative Site 3748

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Ogden : Forest Investigative Site 3963

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Orem : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Riverton : Forest Investigative Site 4008

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Salt Lake City : University of Utah Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Salt Lake City : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Salt Lake City : Forest Investigative Site 3712

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Vermont

South Burlington : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

South Burlington : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

White River Junction : Novartis Investigative Site

A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Virginia

Arlington : Millennium Clinical Trials, L.L.C.

Do you have Chronic Obstructive Pulmonary Disease also known as COPD?

Newport News : Health Research of Hampton Roads, Inc.

Emphysema/COPD/ Chronic Smoker’s Bronchitis Research

Richmond : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Richmond : Virginia Research Center

Adults With COPD - Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease

Richmond : Pulmonary Associates of Richmond, Inc.

Are you being treated for Chronic Obstructive Pulmonary Disease?

Abingdon : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Abingdon : Forest Investigative Site 3047

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Abingdon : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Alexandria : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Arlington : Forest Investigative Site 3730

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charlottesville : University of Virginia

A clinical research study of HXe MRI lung ventilation for the treatment of Asthma, COPD or Healthy

Danville : Forest Investigative Site 3981

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Henrico : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Manassas : Forest Investigative Site 3705

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Midlothian : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Midlothian : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Midlothian : Forest Investigative Site 3776

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Newport News : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Newport News : Forest Investigative Site 3488

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Norfolk : Forest Investigative Site 3852

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Richmond : Virginia Commonwealth University Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Richmond : Pulmonary Associates of Richmond Inc

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Richmond : Virginia Commonwealth University

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease(COPD)

Richmond : Pulmonary Associates of Richmond

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Richmond : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Richmond : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Richmond : 1237.25.10510 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Richmond : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Richmond : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Richmond : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Richmond : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Richmond : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Richmond : Forest Investigative Site 3775

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Richmond : Forest Investigative Site 2460

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Richmond : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Winchester : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Washington

Tacoma : Research Site

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Bellingham : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Bellingham : Forest Investigative Site 2690

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Burien : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Port Orchard : Forest Investigative Site 3711

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Richland : Zain Research LLC

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Seattle : University of Washington Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Seattle : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Spokane : 1237.25.10521 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Spokane : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Spokane : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Spokane : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Spokane : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Spokane Valley : Forest Investigative Site 3127

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tacoma : Franciscan Research Center

A clinical trial seeking patients for a research study for the treatment of Emphysema

Tacoma : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tacoma : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Tacoma : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Tacoma : Forest Investigative Site 2687

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tacoma : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

West Virginia

Bridgeport : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Bridgeport : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Charleston : Forest Investigative Site 3840

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lewisburg : Forest Investigative Site 3823

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Morgantown : 1237.26.10601 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Morgantown : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Morgantown : Forest Investigative Site 3682

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Morgantown : Pearl Investigative Site Updated

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Wisconsin

Madison : University of Wisconsin School of Medicine & Public Health

A clinical trial seeking patients for a research study for the treatment of Emphysema

Middleton : Forest Investigative Site 3660

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Milwaukee : Medical College of Wisconsin Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Verona : Forest Investigative Site 2983

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Verona : Forest Investigative Site 3951

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Argentina

Adrogue : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Bahia Blanca : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Buenos Aires : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Buenos aires : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Buenos Aires : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Buenos Aires : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Buenos Aires : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Buenos Aires : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Buenos Aires : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Buenos Aires : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Buenos Aires : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Ciudad Autnónoma de Buenos Aires : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Ciudad Autonoma de Buenos Aires : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Ciudad Autonoma de Buenos Aires : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Ciudad Autonoma de Buenos Aires : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Ciudad Autónoma de Buenos Aires : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Ciudad de Buenos Aires : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Concepcion del Uruguay : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Concepcion del Uruguay : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Concepción del Uruguay : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Cordoba : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Cordoba : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Cordoba : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Cordoba : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Cordoba : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Cordoba : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Coronel Suarez : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Corrientes : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Derqui, Pilar : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Jujuy : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

La Plata : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

La Plata : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Lanus : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Lanús : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Mar del Plata : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Mar del Plata : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Mar del Plata : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Mendoza : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mendoza : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mendoza : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Mendoza : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Mendoza : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Mendoza : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Monte Grande : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Olivos : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Parana : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pergamino : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Quilmes : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Quilmes : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Quilmes : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Rio Negro : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Rojas : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Rosario : Novartis Investigative Site

A clinical research study of Indacaterol and Salmeterol for the treatment of Chronic Obstructive Pulmonary Disease

Rosario : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Rosario : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Rosario : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Rosario : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Rosario : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Rosario : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Salta : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Salta : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Salta : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

San Isidro : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Isidro : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

San Luis : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Miguel de Tucuman : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

San Miguel de Tucuman : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Miguel de Tucuman : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

San Miguel de Tucumán : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Nicolas : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Nicolas : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Santa Fe : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Santa Fe : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Santa Fe : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Santa Fe : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Santa Fe : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Santa Fe : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Santiago del Estero : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Vicente Lopez : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating QVA149, Tiotropium and placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Australia

Bedford Park : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Cairns : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Daw Park : 1237.26.61002 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Daw Park : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Daw Park : 1237.16.61601 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Footscray : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Geelong : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Murdoch : 1237.26.61005 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Nedlands : 1237.26.61001 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Randwick : GSK Investigational Site

A clinical research study of Fluticasone Propionate / Salmeterol Xinafoate DISKUS and Fluticasone Propionate / Salmeterol Xinafoate ROTACAP for the treatment of Asthma

Randwick : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Asthma

Randwick : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Redcliffe : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Toorak Gardens : 1237.26.61003 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Toorak Gardens : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Austria

Feldbach : 1237.26.43004 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Feldbach : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Feldbach : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Feldbach : Almirall Investigational Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide / Formoterol Fumarate and Salmeterol / Fluticasone to evaluate Pulmonary Disease, Chronic Obstructive

Feldkirch : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Feldkirch : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Feldkirch : Almirall Investigational Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide / Formoterol Fumarate and Salmeterol / Fluticasone to evaluate Pulmonary Disease, Chronic Obstructive

Graz : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Grieskirchen : 1237.26.43002 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Grieskirchen : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Grieskirchen : Almirall Investigational Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide / Formoterol Fumarate and Salmeterol / Fluticasone to evaluate Pulmonary Disease, Chronic Obstructive

Innsbruck : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Linz : 1237.26.43003 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Linz : 1237.26.43006 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Linz : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Linz : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Linz : Almirall Investigational Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide / Formoterol Fumarate and Salmeterol / Fluticasone to evaluate Pulmonary Disease, Chronic Obstructive

Salzburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Salzburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Salzburg : Almirall Investigational Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide / Formoterol Fumarate and Salmeterol / Fluticasone to evaluate Pulmonary Disease, Chronic Obstructive

Thalheim bei Wels : 1237.26.43001 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Thalheim bei Wels : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Thalheim bei Wels : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Vienna : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Vienna : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Wels : 1237.26.43005 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Wels : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Wels : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Belarus

Gomel : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Minsk : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Minsk : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Belgium

Aalst : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Antwerpen :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Baudour : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Brussel : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Brussel : 1237.25.32001 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Brussels : 1237.25.32004 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Bruxelles :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Bruxelles : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bruxelles : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Edegem : University Hospital Antwerp

A clinical research study of intrapulmonary percussive ventilation and standard treatment for the treatment of Chronic Obstructive Pulmonary Disease

Edegem : Antwerp University Hospital

Patients are needed to participate in a clinical research study of Functional Respiratory Imaging to evaluate Pulmonary Disease, Chronic Obstructive

Eupen : 1237.25.32005 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Genk :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Gent : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Gent : 1237.11.32001 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Gilly : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Gosselies : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hasselt : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Jambes : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Jambes : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Kortrijk :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Lebbeke : 1237.25.32003 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Leuven : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Leuven :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Leuven : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Leuven : University Hospital Leuven

Patients are needed to participate in a clinical research study to evaluate Chronic Obstructive Pulmonary Disease

Liège : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Luxembourg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Malmedy/Bellevaux-Ligneuville : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Oostende : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Roeselare : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Turnhout : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Turnhout : 1237.25.32002 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Bosnia and Herzegovina

Banja Luka : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Bihac : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Brcko : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Foca : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Gradiška : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Istocno Sarajevo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Konjic : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Mostar : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Novi Travnik : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sarajevo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sarajevo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Tesanj : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Trebinje : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Zenica : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Brazil

Belo Horizonte : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Florianopolis : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Goiania : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Porto Alegre : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Porto Alegre : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Ribeirao Preto : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Rio de Janeiro : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

São Paulo : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Bulgaria

Blagoevgrad : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Dimitrovgrad : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Dimitrovgrad : Almirall Investigational Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide / Formoterol Fumarate and Salmeterol / Fluticasone to evaluate Pulmonary Disease, Chronic Obstructive

Gabrovo : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Gabrovo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Gabrovo : Almirall Investigational Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide / Formoterol Fumarate and Salmeterol / Fluticasone to evaluate Pulmonary Disease, Chronic Obstructive

Kozlodui : Almirall Investigational Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide / Formoterol Fumarate and Salmeterol / Fluticasone to evaluate Pulmonary Disease, Chronic Obstructive

Lovech : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pazardjik : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Petrich : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Petrich : Almirall Investigational Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide / Formoterol Fumarate and Salmeterol / Fluticasone to evaluate Pulmonary Disease, Chronic Obstructive

Pleven : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Pleven : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Plovdiv : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Plovdiv : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Plovdiv : Almirall Investigational Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide / Formoterol Fumarate and Salmeterol / Fluticasone to evaluate Pulmonary Disease, Chronic Obstructive

Razgrad : Almirall Investigational Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide / Formoterol Fumarate and Salmeterol / Fluticasone to evaluate Pulmonary Disease, Chronic Obstructive

Rousse : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Ruse : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Ruse : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sevlievo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sofia : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sofia : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sofia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sofia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sofia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sofia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sofia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sofia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sofia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sofia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Stara Zagora : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Stara Zagora : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Stara Zagora : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Stara Zagora : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Stara Zagora : Almirall Investigational Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide / Formoterol Fumarate and Salmeterol / Fluticasone to evaluate Pulmonary Disease, Chronic Obstructive

Troyan : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Troyan : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Varna : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Varna : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Veliko Tarnovo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Vidin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Vidin : Almirall Investigational Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide / Formoterol Fumarate and Salmeterol / Fluticasone to evaluate Pulmonary Disease, Chronic Obstructive

Canada

Bolton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Burlington : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Burlington : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Burlington : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Burlington : 1237.25.11505 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Burlington : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Calgary : Updated

A clinical trial to evaluate treatments using Medical tests for patients with Asthma, or Pulmonary Disease, Chronic Obstructive

Calgary :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Calgary : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Calgary : University of Calgary

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Courtice : 1237.26.11609 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Courtice : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Edmonton :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Edmonton : Links Clinic

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Edmonton : Grey Nuns Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Edmonton : University of Alberta Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Gatineau : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Grimsby : 1237.25.11507 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Grimsby : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Halifax : Forest Investigative Site 3652

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hamilton :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Kingston : Kingston General Hospital

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

KIngston : Respiratory Investigation Unit at Kingston General Hospital Updated

Patients are needed to participate in a clinical research study evaluating GSK573719/GW642444 and GSK573719 for the treatment of COPD

Kitchener : Forest Investigative Site 3830

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

La Malbaie : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Langley : Forest Investigative Site 3448

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lethbridge : Lethbridge Regional Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

London : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

London : Forest Investigative Site 3772

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

London : Forest Investigative Site 3754

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Longueuil : Forest Investigative Site 3763

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Mirabel : 1237.26.11611 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Mirabel : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mississauga : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Mississauga : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Moncton : 1237.26.11605 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Moncton : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Moncton : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Moncton : Almirall Investigational Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide / Formoterol Fumarate and Salmeterol / Fluticasone to evaluate Pulmonary Disease, Chronic Obstructive

Montreal : Montreal Chest Institute

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

Montreal : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Montreal : Updated

A clinical trial to evaluate treatments using Medical tests for patients with Asthma, or Pulmonary Disease, Chronic Obstructive

Montreal :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Montreal : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Montreal : Forest Investigative Site 3495

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Montréal : Centre hospitalier de l'Université de Montréal

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease or Metabolic Syndrome

Montréal : Montreal Chest Institute

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease or Metabolic Syndrome

Newmarket : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

North Vancouver : Lion's Gate Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Orleans : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Ottawa : Ottawa Hospital General

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

Ottawa :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Ottawa : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Ottawa : 1237.25.11510 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Penticton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Point Claire : 1237.26.11602 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Pointe-Claire : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Quebec : Institut universitaire de cardiologie et de pneumologie de Québec

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

Quebec : GSK Investigational Site

A clinical research study of Umeclidinium/Vilanterol 62.5/25 mcg and Tiotropium 18 mcg for the treatment of Pulmonary Disease, Chronic Obstructive

Quebec : Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ)

A clinical trial seeking patients for a research study for the treatment of Emphysema

Quebec : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Quebec : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Quebec : 1237.25.11506 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Quebec : 1237.25.11502 Boehringer Ingelheim Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Quebec : Institut universitaire de cardiologie et de pneumologie de Québec

Patients are needed to participate in a clinical research study evaluating ASM-024 and Placebo for the treatment of COPD

Quebec : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Québec : Institut universitaire de cardiologie et de pneumologie de Québec

A clinical study for patients with Pulmonary Disease, Chronic Obstructive

Québec : Institut universitaire de cardiologie et de pneumologie de Québec

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease or Metabolic Syndrome

Québec : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Saint Romuald : Almirall Investigational Site

Patients are needed to participate in a clinical research study of Aclidinium Bromide / Formoterol Fumarate and Salmeterol / Fluticasone to evaluate Pulmonary Disease, Chronic Obstructive

Sainte Foy : Updated

A clinical trial to evaluate treatments using Medical tests for patients with Asthma, or Pulmonary Disease, Chronic Obstructive

Sainte Foy :

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Sainte Jerome : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sainte-Foy : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sainte-Foy : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Saint-Jérôme : Hôpital régional de Saint-Jérôme

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease or Metabolic Syndrome

Sarnia : 1237.26.11608 Boehringer Ingelheim Investigational Site

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Sarnia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Saskatoon : Royal University Hospital

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

Saskatoon : Forest Investigative Site 3753

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstru